Keyphrases
Significant Risk Factors
100%
Acute Lymphoblastic Leukemia
100%
Machine Learning Approach
100%
Pediatric Acute Lymphoblastic Leukemia
100%
Classification and Regression Tree
100%
Hemoglobin
66%
Random Forest
66%
Childhood Acute Lymphoblastic Leukemia
66%
Platelets
66%
Gradient Boosting Machine
66%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
66%
White Blood Cells
66%
Consanguinity
66%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
66%
Male Patients
33%
Inclusion Criteria
33%
Environmental Conditions
33%
Exclusion Criteria
33%
Environmental Factors
33%
Socioeconomic Status
33%
Treatment Outcome
33%
Pediatric Patients
33%
Rural Areas
33%
Future Information
33%
Overall Accuracy
33%
Model Fitting
33%
Drinking Water
33%
Clinical Variables
33%
Misclassification
33%
Machine Learning Techniques
33%
Machine Learning Algorithms
33%
Supervised Machine Learning
33%
10-fold Cross Validation
33%
Blood Biochemistry
33%
Platelet Count
33%
Classification Tree Algorithms
33%
Sample Space
33%
Leukemia Patients
33%
Middle-class Families
33%
Phenotypic Data
33%
C5.0 Decision Tree Algorithm
33%
Fit Accuracy
33%
Regression Tree Algorithm
33%
Feature Attribute
33%
C5.0
33%
Immunology and Microbiology
Leukocyte
100%
Hemoglobin
100%
Random Forest
100%
Consanguinity
100%
Platelet
100%
Supervised Machine Learning
50%
Platelet Count
50%
Decision Tree
50%
Biochemistry, Genetics and Molecular Biology
Leukocyte
100%
Random Forest
100%
Platelet
100%
Consanguinity
100%
Decision Tree
50%
Blood Biochemistry
50%
Platelet Count
50%
Supervised Machine Learning
50%
Agricultural and Biological Sciences
Learning System
100%
Machine Learning
100%
Leukocyte
50%
Environmental Factor
25%
Rural Areas
25%
Drinking Water
25%
Medicine and Dentistry
Pediatrics
100%
Acute Lymphoblastic Leukemia
100%
Platelet
25%
Leukocyte
16%
Consanguinity
16%
Exclusion Criterion
8%
Socioeconomic Status
8%
Cross-Validation
8%
Treatment Outcome
8%
Pediatrics Patient
8%
Environmental Factor
8%
Blood Biochemistry
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Cross-Validation
8%